von Herrath, M., Bain, S. C., Bode, B., Clausen, J. O., Coppieters, K., Gaysina, L., Gumprecht, J.
, Hansen, T. K., Mathieu, C., Morales, C., Mosenzon, O., Segel, S., Tsoukas, G., Pieber, T. R. & Anti-IL-21–liraglutide Study Group investigators and contributors (2021).
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
The Lancet Diabetes & Endocrinology,
9(4), 212-224.
https://doi.org/10.1016/S2213-8587(21)00019-X
Vlasselaers, D., Mesotten, D., Langouche, L., Vanhorebeek, I., van den Heuvel, I., Milants, I., Wouters, P., Wouters, P., Meyns, B.
, Bjerre, M., Hansen, T. K. & Van den Berghe, G. (2010).
Tight glycemic control protects the myocardium and reduces inflammation in neonatal heart surgery.
Annals of Thoracic Surgery,
90(1), 22-9.
https://doi.org/10.1016/j.athoracsur.2010.03.093